Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Prime Medicine, Inc. (PRME) had Cash Flow from Investing Activities of $43.39M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.86M |
|
$-49.12M |
|
-- |
|
$0.86M |
|
$51.51M |
|
$-50.65M |
|
$1.53M |
|
$-49.12M |
|
$-49.58M |
|
$-49.12M |
|
$-49.12M |
|
$-49.12M |
|
$-49.58M |
|
$-50.65M |
|
$-49.23M |
|
177.10M |
|
177.10M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$137.89M |
|
$18.82M |
|
$156.84M |
|
$294.73M |
|
$36.29M |
|
-- |
|
$181.74M |
|
$218.03M |
|
$76.70M |
|
$76.70M |
|
$76.70M |
|
180.62M |
|
| Cash Flow Statement Financials | |
$-42.71M |
|
|
Cash Flow from Investing Activities |
$43.39M |
$0.39M |
|
$76.72M |
|
$77.80M |
|
$1.07M |
|
$4.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.80 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-5917.52% |
|
-5917.52% |
|
-- |
|
-5738.55% |
|
-5738.55% |
|
$-42.92M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-64.04% |
|
-64.04% |
|
-16.67% |
|
-64.04% |
|
$0.42 |
|
$-0.24 |
|
$-0.24 |
|